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Abstract

Smoking remains the single most preventable cause of death worldwide and primary
cause of several types of cancer, cardiovascular disease, and respiratory illness (USDHHS,
2014). Although the prevalence of smoking among the general population continues to decline,
the prevalence of smoking among the veteran population remains high. In addition, the
prevalence of smoking among veterans with substance and alcohol use disorders is 2 to 3 times
higher than in the general population. Over the years, the VA has implemented empirically-based
treatments for smoking cessation to address the cigarette smoking epidemic. These services,
however, are greatly underutilized. Motivational interviewing (MI) has traditionally been used to
treat alcohol dependence; however, its efficacy for smoking cessation has been mixed. There is
some evidence, however, suggesting that MI could be used to motivate smokers to seek
treatment. The purpose of this study was to use a brief MI intervention to motivate veteran
smokers undergoing treatment for substance use to seek smoking cessation services at the VA.
We recruited 60 veterans undergoing substance and alcohol use treatment at the Substance Use
Disorders/Intensive Outpatient Program (SUDs/IOP) at the James A. Haley VA. Participants
were randomized to one of two groups: MI vs. active control. We hypothesized that veterans in
the MI condition would be more likely to seek services for smoking cessation compared to those
in the control condition. Our findings supported our hypothesis: 40% of participants in the MI
condition sought treatment to quit smoking after the intervention compared to 23% of
participants in the control condition (p = .03, controlling for baseline differences in cessation
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motivation). In addition, we found that the MI intervention was most beneficial for individuals
with lower baseline motivation to quit smoking. Although we did not find significant mediators
of the effect of the intervention on our primary outcome, this study showed that a brief MI
intervention can promote seeking of smoking cessation resources.

vi

Introduction

Smoking remains the single most preventable cause of death worldwide, causing
approximately 480,000 deaths per year in the U.S. alone, and costing approximately $289 billion
in annual health-related economic losses (USDHHS, 2014). In addition, cigarette smoking is the
cause of several types of cancer, cardiovascular disease, and respiratory illness (USDHHS,
2014). As of 2015, the prevalence of smoking in the U.S. was 15.1% for all adults, with males
(16.7%) smoking more than women (13.6%) (Jamal, King, Neff, Whitmill, Babb et al., 2016).
Although the prevalence of smoking among the general population continues to decline, the
prevalence of smoking among the veteran population remains high.
Tobacco Use in Veteran Population
Cigarette smoking has been historically prevalent among the military. A culture
supporting cigarette smoking in the military dates back to as early as the Civil War, when
inexpensive tobacco was provided to troops (Klevens, Giovino, Peddicord, Nelson, Mowery, &
Grummer-Strawn, 1995). Later, cigarettes were sent in care packages to soldiers during WWI,
WWII, and the Korean War (Joseph, 1994). In addition, the “smoking break” was used as a
reward or punishment by drill instructors until the late 1980s (Cronan & Conway, 1989;
Conway, 1998), and until recently, cigarettes were widely available inside bases at a discounted
price. A pro-cigarette smoking culture in the military may partially explain why never smokers
begin smoking during service (Hamlett-Berry, Davison, Kivlahan, Matthews, Hendrickson, &

1

Almenoff, 2009). In fact, being in the military is a risk factor for smoking onset (Klevens et al.,
1995).
The prevalence of smoking among the veteran population has been reported to be as high
as 40% (e.g., Brown, 2009; Institute of Medicine, 2009; McKinney, McIntire, Carmody, &
Joseph, 1997; Veterans Health Administration, 2011). Veterans receiving care at Veteran Health
Administration (VA) hospitals are more likely to smoke compared to veterans who are not part
of the system. This difference may be explained by the high prevalence of psychiatric illness and
substance use, and lower socioeconomic status among veterans receiving services at VA
hospitals (e.g., McKinney et al., 1997; Veterans Health Administration, 2011). Furthermore,
compared to non-smoking veterans, veteran smokers are more likely to be non-Hispanic, black,
unemployed, uninsured, and have a combat history (Veterans Health Administration, 2011).
Clearly, veteran smokers are a special population susceptible to nicotine addiction and difficulty
quitting smoking. Thus, smoking cessation efforts targeted toward this population are warranted.
Mental Illness, Substance Use, and Cigarette Smoking in the Veteran Population
Individuals with mental illness are two to three times more likely to smoke (Ziedonis,
Williams, Steinberg, Smelson, Krejci, Sussner, & Founds, 2004; Grant, Hasin, Chou, Stinson, &
Dawson, 2004), with those in mental health treatment reporting the highest nicotine dependence
(American Psychiatric Association, 2006). In fact, almost half of the cigarettes in the U.S. are
consumed by individuals with mental illness (Lasser, Boyd, Woolhandler, Himmelstein,
McCormick, & Bor, 2000). There are possible biological, psychological, social, and
environmental factors that may lead individuals with mental illness and substance use to smoke
heavily (Ziedonis et al., 2004). Some researchers hypothesize that there is a common
psychological (negative affect) or genetic predisposition underlying mental illness and tobacco
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dependence (McCaffery, Niaura, Swan, & Carmelli, 2003; Dierker, Avenevoli, Merikangas,
Flaherty, & Stolar, 2001; Ziedonis et al., 2004). Other researchers suggest that individuals with
mental illness smoke to reduce symptoms of depression, anxiety, boredom, or to improve
memory and attention (Morton & Pradhan, 2001, Ziedonis et al., 2004), thus supporting the selfmedication hypothesis (Cargill, Emmons, Kahler, & Brown, 2001). Social factors, such as low
education and unemployment, which are common among the mentally ill, have been shown to be
risk factors for smoking (Lawn, Pols, & Barber, 2002; Ziedonis et al., 2004).
The VA is the largest provider of mental health treatment in the U.S. (Greenberg &
Rosenheck, 2004). Twenty-five to forty percent of veterans are treated for mental illness by the
VA, and considerably more have untreated mental health problems (Ziedonis et al., 2004).
Veterans with mental illness are two to three times more likely to be heavy smokers compared to
the general population (Duffy, Kilbourne, Austin, Dalack, Woltmann, Waxmonsky, & Noonan
2012); those with substance use disorders having the highest prevalence of smoking, even
compared to veterans with schizophrenia, depression, and bipolar disorder (Veterans Health
Administration, 2006; Institute of Medicine, 2009; Duffy et al., 2012). The high rate of smoking
among veterans with mental illness could be explained by the stress experienced during service
and the smoking-supporting culture discussed above. Veterans with psychiatric illness and
substance use disorders have a higher likelihood of dying from tobacco related illnesses, such as
cardiovascular and respiratory illnesses, cancer, and stroke, compared to the general population
(e.g., Brown, Barraclough, & Inskip, 2000; Hurt, Offord, Croghan, Gomez-Dahl, Kottke et al.,
1996). Research indicates that, despite the high prevalence of smoking and difficulty quitting
(Institute of Medicine, 2009), smokers with mental illness appear interested in quitting and
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engage in quit attempts (e.g., Duffy, Essenmacher, Karvonen-Gutierrez, & Ewing, 2010; Lasser
et al., 2000).
Smoking Cessation among Veterans
Given the economic and health burden caused by tobacco smoking, since the late 1980s,
the Department of Defense (DoD) and VA have put in place policies and services to restrict
smoking and help veterans quit. Some of these policies include the restriction of use of tobacco
products during basic training and restriction of some indoor smoking (McKinney et al., 1997).
The VA effort to reduce tobacco smoking started with the implementation of a smoke-free policy
inside VA hospitals and an order to stop selling tobacco products in stores inside the VA
(McKinney et al., 1997). In addition, each VA hospital designates a coordinator to enforce
smoke-free policies and distribute information about smoking. The majority of VA hospitals
offer empirically-supported smoking cessation treatment (individual and group), telephone
counseling, and nicotine replacement therapy at no charge to patients (Hamlett-Berry et al.,
2009; McKinney et al., 1997). Despite these efforts, smoking cessation services remain
underutilized (Hamlett-Berry et al., 2009; Volpp, Levy, Asch, Berlin, Murphy et al., 2006).
Some research suggests that even though 96% of VA hospitals offer smoking cessation services,
the use of them is as low as 20% by veteran smokers (Hamlett-Berry et al., 2009).
Some evidence indicates that approximately 70% of veterans report interest in quitting
smoking (Miller,1999). Veterans with medical conditions – including tobacco related illnesses –
are more motivated to quit compared to veterans without these conditions (Duffy, Biotti,
Karvonen‐Gutierrez, & Essenmacher, 2011). Although counter-intuitive, some research found
that veterans with mental illness, especially those undergoing substance use treatment, were
more motivated to quit than veterans without mental disorders (Duffy et al., 2011).
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Unfortunately, motivation to quit smoking does not necessarily translate to behavior, as
suggested by the low usage of smoking cessation services among this population (Duffy et al.,
2011).
There are several possible explanations for the lack of translation between motivation and
treatment-seeking behavior. Formal treatment programs may be inconvenient in outpatient
settings due to scheduling conflicts, lack of transportation, and other barriers (Bastian et al.,
2010). Also, research suggest that most smokers want to quit on their own (e.g., Emmons &
Goldstein, 1992; Duffy et al., 2011), possibly explaining why smokers do not get smoking
cessation treatment, such as individual or group therapy. The inconsistency between motivation
to quit smoking and the low use of smoking cessation treatment may indicate a need to better
inform smokers, especially veterans, of all the resources available to them to quit smoking, from
one-to-one treatment sessions to self-help material, provided at and outside of the VA.
There may be other important barriers at work besides the ones presented previously that
prevent veterans from seeking formal smoking cessation treatment, especially in the context of
mental illness and substance use treatment. Patients and staff members often believe that
smoking cessation can complicate substance use treatment, worsen psychiatric symptoms, and
lead to relapse (Duffy et al., 2012). In addition, some believe that individuals with mental illness
are not motivated to quit smoking (Acton, Prochaska, Kaplan, Small, & Hall, 2001; Ziedonis &
Williams, 2003). There is evidence, however, that indicates that individuals with mental illness
are very interested in quitting (e.g., Duffy et al., 2010; Lasser et al., 2000). Other research has
shown that concurrent treatment for nicotine and drug addiction yields positive results (Fiore
Jaen, Baker, Bailey, Bennett, Benowitz, & Dorfman, 2008; Shealy & Winn, 2014). In fact, data
from one Florida VA hospital that has incorporated mandatory nicotine education in their
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substance use recovery program showed that participation in nicotine recovery groups was
related to increased motivation to quit smoking and decreased medical problems (Shealy,
DeBaldo, Kropp, Gary, Egan-Blackwood, & Francis, 2001; Shealy & Winn, 2014). In addition,
in that study, participation in nicotine recovery groups did not interfere with substance use
recovery among individuals with substance use disorders, regardless of comorbid psychiatric
diagnosis. Overall, research suggests that veteran smokers with mental illness seem to be
motivated to quit smoking. This seems contradictory, as the use of smoking cessation services is
low. This possibly indicates that veteran smokers with mental illness may want to quit smoking,
but are not motivated to attend treatment. Interventions, such as Motivational Interviewing, could
increase veteran smokers’ motivation to seek smoking cessation treatment.
Motivational Interviewing for Smoking Cessation
Motivational Interviewing (MI) was originally developed by Miller and Rollnick in 1991
to treat alcohol abuse. Since then, MI has been successfully applied to a multitude of problematic
behaviors such as diet, exercise, drug abuse, weight loss, treatment compliance, and diabetes.
(Burke, Arkowitz, & Menchola, 2003, Knight, McGowan, Dickens, & Bundy, 2006; Rubak,
Sandbæk, Lauritzen, & Christensen, 2005). MI was developed under the premise that motivation
is fluid across time and contexts; therefore, it can change. (Miller, 1994). MI takes a clientcentered and goal directed approach to foster behavior change (Miller & Rollnick, 2002).
The purpose of MI is to help clients explore and resolve discrepancies related to their
behavior. The therapist guides the client or patient in such a way that the client becomes more
likely to take steps toward changing a specific behavior. MI aims to explore and confront
ambivalence through four main principles: expressing empathy, developing discrepancy, rolling
with resistance, and supporting self-efficacy (Miller & Rollnick, 2002; Rollnick, Miller, &
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Butler, 2008). In addition, MI focuses on identifying the problem, increasing motivation to
change, accepting ambivalence, collaborating with the client, and letting the client set the pace
for change (Miller & Rollnick, 2002). There are an additional 8 strategies suggested by the
developers of MI that help increase the likelihood of behavior change. These are providing
advice, eliminating obstacles, offering alternative options, practicing empathy, providing
feedback, affirming what clients say, clarifying goals, and offering help (Rollnick et al., 2008).
Research supports the efficacy of MI in treating a myriad of problematic behaviors (e.g.,
Foley, Duran, Morris, Lucero, Jiang, Baxter et al., 2005; Burke et al., 2003, Madson, Campbell,
Barrett, Brondino, & Melchert, 2009; Hettema, Steele& Miller, 2005). However, the efficacy of
MI for smoking cessation is not well established, mainly because of the smaller number of
studies and the different methodologies used (Hettema et al., 2010; Lai et al., 2010; Piñeiro,
Míguez Varela, & Becoña Iglesias, 2010). A recent meta-analysis, however, showed a moderate
effect of MI for smoking cessation (Lai, Cahill, Qin, & Tang, 2010). The same meta-analysis
showed that sessions longer than 20 minutes were more effective than shorter sessions, and that
single sessions were just as effective as multiple sessions. In general, the majority of studies
showing mixed results on the effect of MI on smoking cessation used abstinence as the outcome
variables. The limited efficacy of MI could be explained by the fact that MI represents a style of
treatment rather than a cessation treatment per se and could indicate that an MI style may not be
sufficient to help individuals quit smoking. However, given that MI’s purpose is to increase
motivation to initiate behavior change, this style of treatment could move smokers into more
intensive and efficacious treatments.
Studies examining treatment adherence and utilization of smoking cessation services as
the primary outcomes show some promising results, especially those recruiting difficult-to-treat
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populations. For instance, a study aimed at motivating smokers with schizophrenia to seek
treatment for smoking cessation found that MI increased treatment-seeking behavior compared
to psychoeducational and minimal-control conditions (Steinberg, Ziedonis, Krejci, & Brandon,
2004). Other studies have shown MI to lead to higher follow-up session attendance among
smokers with psychosis and high impulsivity (Baker, Richmond, Haile, Lewin, Carr, et al., 2006;
Helstrom, Hutchison, & Bryan, 2007), as well as a higher likelihood of following through with
after care treatment among smokers with psychiatric and substance-use disorders (Daley &
Zuckoff, 1998; Martino, Carroll, O'Malley, & Rounsaville, 2000; Swanson, Pantalon, & Cohen,
1999).
The mechanisms of change of MI are not yet fully understood. The research in this area is
limited and mixed because the majority of studies focused on outcomes rather than process
(Copeland, McNamara, Kelson, & Simpson, 2015). Some studies suggest that MI is more
efficacious among those with high impulsivity (Helstrom et al., 2007) and lower motivation to
change (Brown, Ramsey, Strong, Myers, Lejuez, et al., 2003; Miller & Rollnick, 2002; Rollnick
et al., 2008). Whereas some research suggests that MI leads to smoking cessation through its
effects on self-efficacy to quit smoking (Brown et al., 2003), others have failed to find similar
results (Copeland et al., 2015). More research is needed to understand the mechanisms of change
of MI.
The Current Study
As reviewed earlier, a large number of veterans are diagnosed with mental illness and/or
substance use disorders. Also, the majority of these individuals are smokers. Over the years, the
VA has implemented empirically-based treatments for smoking cessation. These services,
however, are underutilized. Research examining the efficacy of MI on smoking cessation
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outcomes, such as abstinence rates, has shown mixed results. However, there is some promising
evidence suggesting that MI could be used to motivate smokers to seek treatment. The purpose
of this initial study was to test a MI intervention to motivate veteran smokers undergoing
treatment for substance use to seek smoking cessation services.
Primary Aims
Specific Aim 1: To test the effect of a MI intervention on smoking cessation treatmentseeking behavior among veterans undergoing substance use treatment at a VA Medical
Center.
Hypothesis 1: Participants randomized to a motivational interviewing condition would
be more likely to seek smoking cessation services offered at the VA (Nicotine Replacement
Therapy [NRT], other cessation medication, individual treatment, or group treatment) as a result
of the MI intervention compared to the control condition. The primary outcome of the study was
treatment-seeking behavior rather than smoking cessation per se.
Secondary Aims
Aim 2: To examine moderators of the effect of MI on smoking cessation treatment-seeking
behavior.
Hypothesis 2: The effect of the MI intervention on smoking cessation treatment-seeking
behavior would be moderated by baseline motivation, impulsivity, treatment expectancies, and
baseline self-efficacy. We expected the treatment effect to be larger among participants with
lower baseline motivation, higher impulsivity, low treatment expectancies (how helpful
treatment can be and whether smoking cessation treatment could interfere with substance/alcohol
use treatment), and lower self-efficacy for quitting smoking.
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Aim 3: To test mediators of the effect of MI on smoking cessation treatment-seeking
behavior.
Hypothesis 3: The effect of the MI intervention on smoking cessation treatment-seeking
behavior would be mediated by changes in motivation, self-efficacy, and treatment expectancies.
Participants who report the highest changes in motivation, self-efficacy, and treatment
expectancies as a result of the MI intervention should be more likely to seek smoking cessation
treatment.
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Method

Experimental Design
The study was conducted using a two-group between-subjects design. It was publicized
as a single session research study designed to compare different ways of discussing smoking
cessation with VA patients. All recruited participants signed consent. After they consented,
participants were screened for eligibility criteria. Those who did not meet criteria discontinued
the study at this point. Eligible participants completed baseline assessments measuring nicotine
dependence, smoking history and status, demographic information, motivation to smoke, selfefficacy to quit smoking, impulsivity, and treatment expectancies. Once baseline measures were
completed, participants were randomized to one of two groups: motivational interviewing or
active control. After the intervention sessions, participants completed measures of motivation to
quit smoking, self-efficacy to quit smoking, treatment expectancies, and treatment fidelity, and
they were compensated for their time. A chart review was conducted by the experimenter to
collect information about treatment-seeking behavior, psychiatric diagnosis, substance use
disorder, and smoking-related illness. The study was approved by the local VA Research and
Development office and University Institutional Review Board.
Participants
Participants were 61 (57 males) current veteran smokers recruited from the Substance
Use Disorder’s Clinic/Intensive Outpatient Program (SUDs/IOP) at the James A. Haley Veterans
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Hospital. SUDs/IOP is a program that offers outpatient comprehensive care to veterans with
substance use disorders. A priori power analyses demonstrated that a sample size of 60 (30
participants per condition) would provide a power of .80 with a two-tailed alpha level of .05 to
show a medium effect size for the primary aim, Specific Aim 1. The power analysis was
computed based on results from similar prior research (Daley et al., 1998; Martin et al., 1999;
Steinberg et al., 2006; Martin et al., 2000), which found approximately 30 percentage points
difference between the two conditions. Anecdotal reports from the SUDs/IOP program indicated
that spontaneous rate of smoking cessation treatment-seeking behavior was about 10%. We
considered the results from these past studies and the baseline treatment-seeking behavior (10%)
from patients at SUDs/IOP to calculate the sample size. Thus, we used .1 (control group) and .4
(MI group) as the estimated proportions.
To participate in the study, participants had to meet the following inclusion criteria: 1)
veteran, 2) able to read and understand English, 3) 18 to 70 years of age, 4) ≥ 5 cigarettes
smoked per day for the past year, 5) have an exhaled carbon monoxide (CO) of 5 ppm or greater,
and 6) not currently enrolled in any formal smoking cessation treatment or support group.
Participants received $25 for their approximately 1.5-hour participation in the study.
Measures
Screening Form. Eligibility screening was conducted in person. A screening form was
used during the initial contact with participants.
Demographic Form. The demographic form was used to gather information regarding
participants’ gender, age, date of birth, education level, occupation, employment status, ethnicity,
racial identity, and marital status.
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Exhaled Carbon Monoxide. Carbon monoxide (CO) level was assessed at baseline to
obtain a biochemical verification of smoking status. The cutoff for eligibility was 5 ppm or
greater (e.g., Deveci, Deveci, Açik, & Ozan, 2004; Perkins, Karelitz, & Jao, 2013).
Smoking Status Form. The Smoking Status Form (SSF) assessed current smoking status
and smoking history. The Fagerström Test for Nicotine Dependence (FTND; Heatherton,
Kozlowski, Frecker, & Fagerström, 1991) was included in the SSF as a measure of nicotine
dependence.
Motivation. The Contemplation Ladder (Biener & Abrams, 1991) is a measure that
assesses current motivation to quit smoking. This measure depicts a ladder that represents a
continuum of readiness to quit smoking, ranging from 0 (No thought of quitting) to 10 (Taking
action to quit). This measure has demonstrated good predictive validity, such that it predicts
future quit attempts and likelihood to take action to quit (Biener & Abrams, 1991). Participants
were also asked to rate their motivation to quit, on a 10-point rating scale, using a single item
(How committed are you to quit smoking?). We also asked participants about their motivation to
seek help to quit smoking using the same 10-point rating scale format.
Treatment Expectancies. Treatment expectancies were assessed with a 3-item measure
assessing participants’ beliefs about the benefits of smoking cessation treatment and whether
they believe that smoking cessation treatment could interfere with their substance and alcohol
use treatment. Participants were asked to answer each item on a 7-point Likert Scale. Baseline
expectancies were explored as possible moderators of the effect of the MI intervention on
treatment-seeking behavior
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Self-efficacy. Self-efficacy to quit smoking was assessed using a single item asking
participants to rate, on a scale from 1 (not at all) to 10 (very), how confident they were about
their ability to quit smoking. We also asked about self-efficacy to seek help quitting smoking.
Barratt Impulsiveness Scale. The Barratt Impulsiveness Scale (BIS-11; Patton,
Stanford, & Barratt, 1995) is a 34-item self-report measure of trait impulsivity. Participants were
asked to rate, on a scale from 1 (Rarely/Never) to 4 (Almost Always/Always), how they act and
think in different contexts. Impulsivity was explored as a possible moderator of the effect of the
MI intervention on treatment-seeking behavior.
Motivational Interviewing Treatment Integrity Scale. The Motivational Interviewing
Treatment Integrity scale (MITI; Moyers, Martin, Manuel, Hendrickson, & Miller, 2005) was
used to measure treatment fidelity. A random sample of 10 audiotapes from each condition was
selected. The therapist’s supervisor, who was blind to condition, rated the therapist on a 7-point
Liker scale, on empathy, MI spirit, giving information, MI adherent behaviors, reflections, and
open questions. Higher scores indicated higher levels on the two constructs. A patient report of
topics covered during the session was added as a secondary measure of fidelity.
Mental Illness. The experimenter collected information about psychiatric diagnosis,
substance use disorder, psychiatric medication, and medical conditions through chart review.
This information was recorded in the Psychiatric Diagnoses Record Form.
Treatment-Seeking Behavior. Treatment-seeking behavior was operationalized as
action from the patient to request smoking cessation treatment (NRT, other medication,
individual or group counseling) from psychiatrists, nurses, and psychologists at SUDS/IOP.
Patients at the VA can request a prescription for nicotine replacement therapy at no cost. The VA
also offers a manualized and empirically-based individual smoking cessation treatment based on
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Cognitive Behavioral Therapy. At the VA, all patient and provider contact is recorded in the
patient’s medical chart. The experimenter reviewed the patient’s medical record at the end of
their substance use treatment (2 to 5 weeks after the study intervention) to collect information
about smoking cessation services requested by the participant. At the end of the intervention,
participants were provided a handout describing the services available to them and how to get
them. The contact information of the staff psychologist who provides smoking cessation
counseling at the outpatient clinic was added in the handout. Participants were asked to contact
her to schedule an appointment for smoking cessation counseling. She assisted with tracking of
all individuals who request services for smoking cessation through her. All SUDs/IOP patients
completed an exit interview upon completion of the outpatient substance use program.
Questions about quit attempts and use of e-cigarettes to aid smoking cessation were added to the
exit interview.
Procedures
Recruitment. Recruitment of participants occurred during a weekly tobacco recovery
education class, which is required as part of the program to all enrollees, including nonsmokers.
Enrollees attend this class while they participate in the program. The class is led by different
providers, and the number of classes attended by each patient varies. In addition, patients may
enroll in SUDS/IOP several times as they relapse, which means that they could repeat the
nicotine recovery education class several times. During the nicotine recovery class, patients are
informed about quit aids (what is available and what they are), and they discuss triggers to
smoke, reasons to quit smoking, and barriers to quitting smoking. In addition, they are informed
about the smoking cessation services offered at the clinic. This education class is conducted in a
group, lecture format by different providers, and it does not follow any particular protocol or
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schedule. The content of the class may include some aspects of cognitive behavioral therapy
(discussing barriers to quit and triggers for smoking) and motivational interviewing (discussing
reasons to quit smoking). This class posed several challenges to the study. First, the variability
in class topics, providers, content, and attendance introduced error variance that could have made
it more difficult to find significant differences between the conditions. Second, whereas the goal
of the study was to motivate patients to seek smoking cessation treatment, this class could be
conceptualized as a similar program that all participants already received to some degree.
However, was largely ineffective as such, and it historically has not resulted in more than 10% of
participants seeking additional smoking cessation assistance. Thus, there was sufficient room for
improvement via the interventions tested in the present study.
The experimenter attended the weekly tobacco recovery education class to make veterans
aware of the study. Interested participants were able to schedule an appointment with the
experimenter at the end of the class.
Consent. Before screening for eligibility criteria and the experimental procedures, the
experimenter explained the study’s procedures and purposes to the participants. The
experimenter went through a consent form with the participants, in which their rights as human
research participants were described. Participants were asked to sign the informed consent and a
HIPAA form upon agreeing to participate in the study.
Screening. Consented participants were screened for eligibility. The Screening Form was
completed with participants. In addition, participants were asked to provide a breath sample to
measure CO levels to verify smoking status. Participants who did not meet eligibility criteria
discontinued the study at this point.
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Baseline Measures. Eligible participants were asked to complete baseline measures.
These included the demographic form, smoking status form, Contemplation Ladder (baseline
motivation), baseline self-efficacy to quit smoking, impulsivity, and treatment expectancies.
Randomization. After completion of the baseline questionnaires, participants were
randomized (using www.randomizer.org) to one of two conditions: 1) motivational interviewing,
or 2) health education control.
Intervention. After randomization, participants underwent an intervention (MI or health
education control). The intervention occurred within the first 2 weeks of participant recruitment
(the first or second week of substance use treatment). Participants underwent an MI or Health
Education intervention that lasted approximately 40 minutes.
Post-intervention measures. After the intervention, participants were asked to complete
measures that assessed motivation to quit smoking, self-efficacy, and treatment expectancies.
Follow-up. The experimenter collected information about treatment seeking behavior
through chart review at the end of the substance use treatment.
Interventions
Training and treatment fidelity. The experimenter received training from experienced
MI trainers, who are affiliated with The Motivational Interviewing Network of Trainers (MINT).
The experimenter received 20 hours of training. Supervision was provided by an experienced
clinician once per week and as needed throughout the recruitment process. As described earlier,
the supervisor blindly completed the MITI using 10 audiotapes selected at random from each
condition.
MI. The MI intervention was based on the concepts outlined by Miller and Rollnick
(1991, 2002, 2008, 2009). MI is not an intervention or treatment modality per se; rather, MI can
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be described as a person-centered, therapeutic or collaborative conversation style that is intended
to build up an individual’s motivation and commitment to change (Miller & Rollnick, 2008,
2009). MI’s primary goal is to address an individual’s ambivalence about behavior change. MI
intends to engage a person in a conversation about problematic behavior while expressing
empathy, eliciting ambivalence, rolling with resistance, and increasing self-efficacy to change
(Miller & Rollnick, 2002). The role of a therapist that uses MI is to assist individuals verbalize
discrepancies between their behavior and goals and resolve them (Miller & Rollnick, 2002). The
purpose of our sessions was consistent with the MI spirit, which includes expressing empathy,
eliciting ambivalence, rolling with resistance, and increasing self-efficacy to quit smoking
(Miller & Rollnick, 2002). The intervention lasted approximately 40 minutes and concluded with
information about the smoking cessation resources that are available at the outpatient substance
use clinic.
Health Education Control. Participants in the control condition completed baseline
measures and underwent a smoking history interview. The Smoking Status Form was used to
guide the interview. The interview consisted of asking participants questions about their
experience with cigarette smoking, maintenance of smoking, quit attempts, and family history of
cigarette smoking. In addition, the intervention included educational information about smokingrelated illnesses. The experimenter presented information about prevalence and etiology of
several diseases that are a direct consequence of smoking cigarettes, such as multiple cancers,
cardiovascular disease, diabetes, respiratory illnesses, stroke, and hypertension. Participants were
allowed to share and discuss concerns about smoking in ways that relate to their health. The
intervention concluded with information about the smoking cessation resources that are available
at the outpatient substance use clinic. Previous studies have shown this type of intervention to be
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credible and helpful to smokers undergoing treatment for smoking cessation (Webb, de Ybarra,
Baker, Reis, & Carey, 2010). The health education control intervention lasted approximately 40
minutes, matching the MI intervention.
The length of the interventions (minutes) were recorded to assure that there were no
significant differences in contact time between the two conditions. Participants in both
conditions completed the same protocol (same measures in the same order) and only the content
of the interventions differed.

19

Results

Demographics Characteristics
Figure 1 shows the study’s recruitment progression from screening to completion of
study session. Out of 68 consented participants, 61 met eligibility criteria and 7 failed screening.
The 7 consented individuals who failed screening smoked fewer than 5 cigarettes per day and
had a breath CO level below 5 ppm. The data from one consented and eligible participant were
excluded from analyses due to a non-study related hospitalization one week after completing the
study session; thus, outcome data were not available for this participant. Analyses were
conducted with data from 60 eligible participants.
Baseline demographic characteristics and smoking-related variables for the two groups
were compared using Chi-square for categorical variables and independent-t tests for continuous
variables (see Table 1). Between-group baseline differences were found on ethnicity (p = .02),
FTND (p = .04), and baseline motivation to quit smoking (p = .08). Regression analyses were
conducted to test whether these variables predicted the outcome. Only baseline motivation to quit
smoking predicted treatment seeking behavior post-intervention β = .29, p = .02; therefore, it was
included in the primary analyses as a covariate.
Specific Aim 1
We predicted that individuals in the MI condition would be more likely to engage in
smoking cessation treatment compared to those in the control condition. Overall, 31.67% (n =
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19) participants sought treatment after the intervention and 68.33 % (41) did not. In the MI
condition, 40% (n = 12) of participants sought treatment for smoking cessation following the
intervention, compared to 23.3% (n = 7) of participants in the control condition. A logistic
regression was conducted to test the effect of the intervention on smoking cessation treatmentseeking behavior with and without baseline motivation to quit smoking entered in the model as a
covariate. When entering condition alone in the logistic regression model, the results showed that
condition was not predictive of the outcome, β = .78, Wald X2 (1) = 1.89, p = .17, OR = 2.19,
95% CI [.72, 6.70]. However, after controlling for baseline motivation to quit smoking, condition
significantly predicted the outcome, β = 1.47, Wald X2 (1) = 4.54, p = .03, OR = 4.34, 95% CI
[CI = 1.13, 16.72], such that individuals in the MI condition were more likely to seek treatment
to quit smoking than individuals in the health education control condition.
Table 2 shows the type of treatment sought by participants by group. A chi-square test for
independence, with Fisher’s exact correction, was conducted to examine preference of treatment
between the groups. There were no significant differences between conditions on type of
treatment sought, X2 (1, n = 30) = 3.74, p = .50. A chi-test goodness of test was conducted within
each group to determine whether at least one type of treatment was preferred over the others.
These tests were corrected using the Fisher’s Exact method, given that some of the cells had
fewer than five cases. The chi-square goodness of fit test for the MI group showed that at least
one type of treatment was preferred over the others, X2 (3, N = 30) = 8.00, p = .046. However,
follow-up, pair-wise comparison tests showed that individuals in the MI condition showed a nonsignificant preference for NRT over medications, X2 (1, N = 30) = 4.50, p = .07, or combination
therapy, X2 (1, N = 30) = 4.50, p = .07. A similar analysis was conducted to assess whether
smokers in the control condition prefer at least one type of treatment over the others. The chi-
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square goodness of fit test for the control condition indicated that there was no significant
difference in the type of treatment in which smokers in the health education condition engaged,
X2 (2, N = 30) = .29, p = .10.
Secondary Aim 2
Motivation to Quit Smoking. We predicted that the effect of the intervention on
smoking cessation treatment-seeking behavior would be moderated by baseline motivation to
quit smoking, such that the treatment effect would be larger among participants with lower
baseline motivation to quit smoking. To test this hypothesis, we implemented a logistic
regression analysis by entering baseline motivation to quit smoking, condition, and the
interaction term between these two variables in the model. The logistic regression showed a main
effect of baseline motivation to quit smoking, β = 2.51, Wald X2 (1) = 4.425, p = .02, OR =
12.27, 95% CI [1.19, 126.75], a main effect of Condition, β = 3.80, Wald X2 (1) = 4.98, p = .03,
OR = 44.78, 95% CI [1.59, 1263.52], and a trending interaction, β = -1.15, Wald X2 (1) = 3.59, p
= .06, OR = .32, 95% CI [.10, 1.04]. To follow up, we dichotomized baseline motivation to quit
smoking using a median split (Median = 5.50) and plotted the effect of the condition on seeking
treatment to quit smoking by baseline motivation level (high and low). See Figure 2.
As predicted, these findings suggest that among individuals with low baseline motivation
to quit smoking, the MI intervention had the greatest effect on treatment-seeking behavior, X2 (1,
n = 30) = 5.46, p = .02. Indeed, only in the MI condition did any individuals with low baseline
motivation end up seeking treatment. Although this figure also suggests that health education
had a greater effect among participants with high baseline motivation to quit smoking, this
difference was not statistically significant, X2 (1, n = 30) = .72, p = .79.
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Self-efficacy to Quit Smoking. We predicted that the effect of the intervention on
smoking cessation treatment-seeking behavior would be moderated by baseline self-efficacy to
quit smoking, such that the treatment effect would be larger among participants with lower
baseline self-efficacy to quit smoking. We conducted a logistic regression, with and without
baseline motivation to quit smoking entered in the model as a covariate, to test our hypothesis.
When baseline motivation to quit smoking was entered in the model, we found a main effect of
condition, β = 1.69, Wald X2 (1) = 4.66, p = .03, OR = 5.42, 95% CI [1.17, 25.12], but failed to
find a main effect of baseline self-efficacy to quit smoking, β = .39, Wald X2 (1) = .62, p = .43,
OR =1.47, 95% CI [.56, 3.85], or an interaction between baseline self-efficacy to quit smoking
and condition, β = -2.12, Wald X2 (1) = .57, p = .45, OR = .81, 95% CI [.47, 1.40]. When
baseline motivation to quit smoking was not included as a covariate in the model, we failed to
find a main effect of condition, β = 1.25, Wald X2 (1) = 3.24, p = .07, OR = 3.50, 95% CI [.90,
13.66], a main effect of baseline self-efficacy to quit smoking, β = .52, Wald X2 (1) = 1.26, p =
.26, OR = 1.69, 95% CI [.68, 4.19], or a significant interaction, β = -.17, Wald X2 (1) = .431, p =
.51, OR = .84, 95% CI [.50, 1.41]. Thus, our hypothesis that baseline self-efficacy to quit
smoking would moderate the effect of the intervention on treatment-seeking behavior was not
supported.
Impulsivity. Based on prior literature, we hypothesized that impulsivity would moderate
the effect of the intervention on treatment-seeking behavior, such that we expected the treatment
effect to be larger among participants with higher Impulsivity scores at baseline. We
implemented a logistic regression to test our hypothesis, with and without baseline motivation to
quit smoking entered in the model. When baseline motivation to quit smoking was included as a
covariate in the model, we found a main effect of baseline motivation to quit smoking, β = .37,
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Wald X2 (1) = 6.76, p = .01, OR = 1.45, 95% CI [1.10, 1.91], a main effect of condition, β = 1.56,
Wald X2 (1) = 4.94, p = .03, OR = 4.74, 95% CI [1.10, 18.71], but failed to find a main effect of
Impulsivity, β = -.05, Wald X2 (1) = .35, p = .56, OR = .95, 95% CI [.81, 1.12], or an interaction
between Impulsivity and Condition, β = .03, Wald X2 (1) = .37, p = .54, OR = 1.03, 95% CI [.93,
1.14]. When baseline motivation to quit smoking was excluded from the model, we failed to find
a main effect of condition, β = .94, Wald X2 (1) = 2.53, p = .11, OR = 2.57, 95% CI [.80, 8.23], a
main effect of Impulsivity, β = -.02, Wald X2 (1) = .10, p = .75, OR = .98, 95% CI [.84, 1.13], or
an interaction between the two, β = 0.15, Wald X2 (1) = .11, p = .74, OR = .10, 95% CI [.93,
1.11]. These findings do not support our hypothesis that Impulsivity would moderate the effect
of the intervention on the outcome.
Treatment Expectancies. This study included three items about treatment expectancies,
which were measured before and after the intervention. These items were: 1) Quitting smoking
will help me become free of drugs and alcohol (Expectancy 1), 2) Quitting smoking will lead me
to relapse from substance/alcohol use (Expectancy 2), and 3) Counseling for smoking cessation
at the VA can help me quit smoking (Expectancy 3). Baseline and post-intervention means and
standard deviations are shown in Table 3.
Logistic regression analyses were conducted to examine the ability of baseline Treatment
Expectancies to moderate the effect of the intervention on smoking cessation treatment-seeking
behavior. We conducted these analyses with and without baseline motivation to quit smoking as
a covariate. We expected the effect of the intervention to be greater among individuals with
lower scores on the Treatment Expectancies at baseline. The findings show that baseline
treatment expectancies did not moderate the effect of the intervention on the study outcome. The
results remained the same when baseline motivation to quit smoking was excluded from the
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logistic regression model. Results (including baseline motivation to quit smoking as a covariate)
are presented in Table 4.
Secondary Aim 3
We hypothesize that the effect of the MI intervention on smoking cessation treatmentseeking behavior would be mediated by the changes in motivation and self-efficacy, such that we
expect that participants who report the highest changes in motivation and self-efficacy as a result
of the MI intervention will be more likely to seek smoking cessation treatment.
Motivation Change. Prior to conducting the mediation analysis to test the ability of
motivation change to predict the effect of the intervention, we explored changes in motivation as
a result of the intervention. Table 5 shows the means and standard deviations for baseline and
post-intervention motivation to quit smoking per condition.
We conducted a Repeated Measures ANOVA to examine the effects of time, condition,
and the interaction between the two. This analysis yielded a significant main effect only for
Time, F (1, 58) = 36.68, p < .01, but no main effect of condition, F (1, 58) = 1.59, p = 2.13, or
time by condition interaction, F (1, 58) = 2.62, p = .11. These results suggest that motivation to
quit smoking increased significantly from baseline to post-intervention, regardless of condition.
Given that the groups did not differ in motivational change, mediation effects were
unlikely. Nevertheless, we conducted a mediation analysis using the bootstrapping procedure via
the PROCESS macro developed by Hayes (2013) to explore the ability of motivation to quit
smoking to mediate the relationship between condition and outcome. Baseline motivation to quit
smoking was included in the mediation models as a covariate. Although the effect of condition
on treatment-seeking behavior was significant, b = 1.48, SE = .69, p = .03 (path c), neither the
effect of condition on motivation change, (path a), b = .56, SE = .54, p = .31, nor the effect of
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motivation change on treatment seeking, (path b), b = .17, SE .18, p = .34, were significant.
Moreover, the model showed that condition remained a significant predictor of treatment-seeking
behavior when motivation change was entered in the model (c’) b = 1.37, SE = .70, p = .05.
Thus, these results do not support mediation by motivation change.
Self-efficacy Change. Prior to conducting the mediation analysis to test the ability of
self-efficacy change to predict the effect of the intervention, we explored changes in self-efficacy
in the context of the intervention. We conducted a Repeated Measures ANCOVA. Baseline
motivation to quit smoking was included in the model as a covariate. This analysis yielded a
significant effect of time, F (1, 57) = 7.54, p = .01. We failed to find a significant effect of
condition, F (1, 57) = .00, p = .99, or interaction between condition and time, F (1, 57) = 1.60, p
= .21. These results suggest that self-efficacy to quit smoking scores increased significantly from
baseline to post-intervention, regardless of condition.
A similar mediation analysis approach was used to explore the ability of self-efficacy
change to mediate the relationship between condition and outcome. Although the effect of
condition on treatment-seeking behavior was significant, b = 1.48, SE = .69, p = .03 (path c),
neither the effect of condition on self-efficacy change (path a), b = .69, SE = .54, p = .21, nor the
effect of self-efficacy change on treatment-seeking behavior (path b), b = .18, SE = .16, p = .25,
were significant. In addition, the model showed that condition remained a significant predictor of
treatment-seeking behavior when self-efficacy change was entered in the model (c`), b = 1.36,
SE = .70, p = .05. These findings do not support mediation by self-efficacy change.
A similar mediation analysis was used to explore the ability of treatment expectancy
change to mediate the relationship between condition and outcome. The mediation model that
included treatment expectancy 1 as a mediator showed that although the effect of condition on
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treatment-seeking behavior was significant, b = 1.48, SE = .69, p = .03 (path c), neither the effect
the effect of condition on expectancy change 1 (path a), b = .15, SE = .25, p = .57, nor the effect
of self-expectancy change 1 on treatment-seeking behavior (path b), b = .08, SE = .33, p = .81,
were significant. In addition, the model showed that condition remained a significant predictor of
treatment-seeking behavior when self-efficacy change was entered in the model (c`), b = 1.46,
SE = .69, p = .03. These findings do not support mediation by expectancy 1 change.
The mediation model with treatment expectancy 2 change included as a mediator showed
a significant effect of condition on treatment-seeking behavior was significant (path c), b = 1.49,
SE = .69, p = .03 (path c). However, neither the effect of condition on expectancy 2 change (path
a), b = -.02, SE = .25, p = .92, nor the effect of self-expectancy 2 change on treatment-seeking
behavior (path b), b = .20, SE = .32, p = .52, were significant. Furthermore, condition remained a
significantly predictor of treatment-seeking behavior, b = 1.48, SE = .69, p = .03 (c`), when
treatment expectancy change 2 was entered in the model. These findings do not support
mediation by expectancy 2 change.
The mediation model with treatment expectancy 3 change included as a mediator showed
a significant effect of condition on treatment-seeking behavior was significant (path c), b = 1.52,
SE = .71, p = .03. However, neither the effect of condition on expectancy 3 change (path a), b = .48, SE = .32, p = .14, nor the effect of self-expectancy 3 change on treatment-seeking behavior
(path b), b = .08, SE = .27, p = .76, were significant. Furthermore, condition remained a
significantly predictor of treatment-seeking behavior, b = 1.51, SE = .71, p = .03 (c`), when
treatment expectancy 3 change was entered in the model. These findings do not support
mediation by expectancy 3 change.
Exploratory Analyses
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During chart review, we collected information on the participants’ number of co-morbid
psychiatric diagnoses, number of medical conditions, number of psychotropic medications, and
number of medications prescribed for medical needs. We explored whether the intervention’s
effectiveness differed depending on the psychological and health presentation of participants.
First, we tested whether the two conditions differed in these variables at baseline by conducting
an Independent Samples t-tests. See Table 6. The groups were indistinguishable in number of
co-morbid psychiatric diagnoses, number of psychotropic medications, number of medical
conditions, and number of medications for medical conditions at baseline. Then, we calculated
the phi coefficient between the outcome--treatment-seeking behavior--and the variables
mentioned above. See Table 7. We found that treatment-seeking behavior was significantly
related to number of medical conditions and number of medications taken for these conditions.
We also explored whether the effect of the intervention on the outcome was moderated
by number of psychiatric diagnoses, number of medical conditions, number of psychotropic
medications, or number of medications. We conducted a logistic regression to explore the latter,
which did not reveal significant interactions between condition and any of these variables.
Taken together, these exploratory analyses suggest that participants with a larger number of
medical diagnoses and who are prescribed a larger number of medications to treat these
conditions are more likely to engage in smoking cessation treatment, independent of type of
intervention.

Treatment Fidelity
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Our intention was to match the two conditions on session length. As expected, length of
session (minutes) did not significantly differ between the MI (M = 35.14, SD = 5.64) and Health
Education (M = 38.00, SD = 7.42) conditions, t (56) = 1.64, p = .11.
We used two methods to assess treatment integrity. The first method consisted of a
patient self-report measure of topics covered during the session. Items 1 – 10 included topics
covered during the MI session and items 11 – 18 included topics covered during the Health
Education Control session. The supervisor – blind to condition - also rated the therapist, on 7point Liker scales, on empathy, MI spirit, giving information, MI adherent behaviors,
reflections, and open questions. Higher scores on MI recordings indicated higher levels of
adherence to the MI spirit, whereas lower scores on the Control recordings indicated lower
levels of adherence to the MI spirit in that condition.
Independent t-tests were conducted to examine differences between groups on the selfreport measure of topics covered during the session. The first t-test showed that participants in
the MI condition (M = 9.14, SD = 1.22) endorsed items consistent with the MI session
significantly more than participants in the control group (M = 8.00, SD = 1.67), t (58) = -2.97, p
< .01. The second t-test showed that participants in the control condition (M = 5.07, SD = 1.20)
endorsed items consistent with the control session significantly more than participants in the MI
condition (M = 2.57, SD = 1.94), t (58) = -2.97, p < .01. Analysis of the supervisor rated audio
recordings revealed a significant difference in MI spirit adherence between the MI (M = 27.40,
SD = 4.20) and Health Education (M = 17.70, SD = 1.42) conditions, t (18) = -6.93, p < .01,
suggesting higher adherence to the MI spirit when conducting the MI intervention.
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Table 1
Demographic Characteristics and Smoking Variables of Participants at Baseline for Full Sample
and by Condition (N = 60)
Variable

Age (M, SD)
Male
Race
American Indian/Alaskan Native
Asian
Native Hawaiian/Other Pacific Islander
African American
Caucasian
Hispanic
Marital Status
Single
Married
Separated
Divorced
Widowed
Income
Under $10,000
$10,000 - $19,000
$20,000 – $29,000
$30,000 – $39,000
$40,000 – $49,000
$50,000 – $59,000
$60,000 – $69,000
$70,000 – $79,000
$80,000 – $89,000
Over $90,000
Education
Did not graduate HS
High school graduate
Some college
Technical school/Associates
4-year college
Some school beyond 4-year college
Professional degree (MD, JD, PhD)
CPD (M, SD)
FTND (M, SD)
Years Smoking (M, SD)
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MI
Condition
n (%)
50.17
(11.96)
28 (93.3)

Control Condition
n (%)

p

48.30 (11.75)

.54

29 (96.7)

.55

1 (3.3)
0
0
17 (56.7)
12 (40.0)
0

0
1 (3.3)
0
12 (40.0)
17 (56.7)
5 (16.7)

.29

11 (36.7)
7 (23.3)
5 (16.7)
7 (23.3)
0

10 (33.3)
2 (6.7)
8 (26.7)
8 (26.7)
2 (6.7)

.23

16 (53.3)
7 (23.3)
2 (6.7)
0
2 (6.7)
1 (3.3)
0
1 (3.3)
0
1 (3.3)

13 (43.3)
8 (26.7)
4 (13.3)
1 (3.3)
1 (3.3)
1 (3.3)
0
0
2 (6.7)
0

.61

0
11 (36.7)
11 (36.7)
4 (13.3)
1 (3.3)
3 (10)
0
17.7 (9.68)
4.33 (1.06)
30.63
(14.95)

2 (6.7)
4 (13.3)
15 (50.0)
7 (23.3)
1 (3.3)
1 (3.3)
0
16.43 (7.62)
3.733 (1.17)
29.05 (14.75)

.17

.02*

.58
.04*
.68

Table 1 (Continued)
Variable

CO (M, SD)
Baseline Motivation to Quit Smoking (M, SD)
Baseline Self-efficacy to Quit Smoking (M,
SD)
Impulsivity (M, SD)

MI
Condition
n (%)

Control Condition
n (%)

p

29.93
(16.30)
4.97 (2.92)
4.90 (2.78)

28.23 (12.79)

.66

6.30 (2.87)
6.00 (2.63)

.08
.12

69.43
68.59 (12.95)
.81
(13.60)
Expectancy 1 (M, SD)
3.07 (1.55)
3.10 (1.58)
.94
Expectancy 2 (M, SD)
1.43 (1.01)
1.50 (0.93)
.79
Expectancy 3 (M, SD)
3.57 (1.19)
3.63 (0.99)
.82
Note: HS = High School; MD = Medical Doctor; JD = Juris Doctor; Ph.D. = Doctor in
Philosophy; CPD = Cigarettes Per Day; FTND = Fagerstrom Test for Nicotine Dependence; CO
= Carbon Monoxide Level (ppm); The Contemplation Ladder was used to measure Baseline
Motivation to Quit Smoking; Impulsivity was measured using the Barratt Impulsivity Scale;
Self-efficacy to Quit Smoking was measured with a single item asking participants to rate how
confident they are about their ability to quit smoking; Expectancies for treatment were measured
with three items assessing whether they believe that smoking cessation treatment could interfere
with their substance and alcohol use treatment and whether they think the VA could help them
quit smoking.
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Table 2
Type of Treatment Sought by Participants by Condition
Type of Treatment

MI

Health Education Control

Counseling

3

2

NRT

7

3

Medication

1

0

Combination Therapy

1

2

Note: NRT = Nicotine Replacement Therapy; Medication = Buproprion or Chantix; Combination Therapy =
Counseling + Medication
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Table 3
Means and Standard Deviations for Baseline and Post-Intervention Treatment Expectancies by
Condition
Baseline

Post-Intervention

MI

Control

p

MI

Control

p

Expectancy 1

3.07 (1.55)

3.10 (1.58)

.94

3.43 (1.61)

3.33 (1.67)

.81

Expectancy 2

1.43 (1.01)

1.50 (0.93)

.79

1.40 (.894)

1.47 (0.90)

.77

Expectancy 3

3.57 (1.19)

3.63 (0.99)

.82

3.97 (1.38)

4.50 (0.78)

.07
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Table 4
Summary of Logistic Regression Analysis for Treatment Expectancies Predicting TreatmentSeeking Behavior while Controlling for Baseline Motivation to Quit Smoking

B

SE B

eB

Baseline Motivation

.39**

.15

1.47

Condition

4.04*

1.92

56.96

Expectancy 1

1.23

.81

3.42

Condition x Expectancy 1

-.73

.48

.48

Baseline Motivation

.42**

.15

1.52

Condition

.38

1.19

.75

Expectancy 2

-1.18

1.15

.31

Condition x Expectancy 2

.81

.74

.25

Baseline Motivation

.38**

.14

1.45

Condition

2.31

2.32

10.10

Expectancy 3

.40

1.00

1.49

Condition x Expectancy 3

-.23

.59

.78

Predictor
Expectancy 1

Expectancy 2

Expectancy 3

Note: * p < .05, ** p < .01, * p < .001.

34

Table 5
Baseline and Post-Intervention Statistics for Motivation to Quit Smoking and Self-Efficacy
Baseline

Post-Intervention

MI

Control

p

MI

Control

p

Motivation to Quit

4.97 (2.92)

6.30 (2.87)

.08

7.10 (3.25)

7.53 (2.61)

.57

Self-efficacy

4.90 (2.92)

6.00 (2.63)

.12

6.57 (3.20)

6.90 (2.51)

.66
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Table 6
Baseline Characteristics for Co-Morbid Psychiatric Diagnoses, Psychotropic Medications,
Medical Conditions, and Medications Taken for Medical Conditions.

MI

Control

M (SD)

M (SD)

p

Psychiatric diagnoses

2.37 (1.00)

2.63 (1.47)

.41

Psychotropic medications

2.03 (1.56)

2.10 (1.49)

.87

Medical conditions

6.57 (4.47)

6.47 (3.24)

.92

Medications (health)

7.00 (4.43)

5.37 (4.34)

.15
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Table 7
Correlations Between Outcome and Number of Psychiatric Conditions, Number of Psychotropic
Medications, Number of Medical Conditions, And Number of Medications for Medical
Conditions.

Treatment-seeking Behavior

Psychiatric

Medical

Psychotropic

Medications

diagnoses

conditions

medications

(Health)

-.015

.273*

-.006

.454***

Note: * p < .05, ** p < .01, *** p < .001.

37

Total number of people in program
from Feb 2016 – June 2016
n = 100

Estimated Smokers
n = 80
Not Randomized
Ineligible
n=7
Provided Informed Consent

n = 1 using e-cigarettes only

n = 68

n = 4 smoking < 5 CPD
n = 2 using NRT or in counseling
for smoking cessation

Randomized
n = 61
Withdrawn from Study
n=1

Motivational Interviewing

Health Education Control

n = 30

n = 30

Data analyzed

Data analyzed

n = 30

n = 30

Figure 1. Participant flow through consent, screening, and enrollment.
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9

p = .02

Sought Treatment to Quit

8

p = .79

7
6
5

MI

4

Health Education

3
2
1
0
Low Motivation

High Motivation

Figure 2. Effect of intervention on treatment-seeking behavior by baseline motivation to quit smoking.
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Discussion

The present randomized, controlled study provides support for the usefulness of MI in
engaging veteran cigarette smokers undergoing treatment for substance use in smoking cessation
treatment. We found that veteran smokers randomized to the MI condition were more likely to
engage in smoking cessation treatment compared to veteran smokers randomized to the health
education condition, when group differences in baseline motivation were accounted for. There
was a tendency for veteran smokers in the MI condition to prefer NRT over counseling. This
observation is consistent with previous studies that have found greater preference for NRT
among smokers with a history of substance dependence (Cooney, Cooney, Perry, Carbone,
Cohen et al., 2009). Although the interaction just missed statistical significance, our results also
suggest that the MI intervention was most effective among veterans who had low baseline
motivation to quit smoking. These results are consistent with MI theory, as this intervention was
developed to increase motivation among individuals who are ambivalent about behavioral
change and have low motivation to do so (Miller & Rollnick, 2002).
Our results are consistent with previous studies that found a significant effect of MI on
increasing treatment-seeking behavior compared to psychoeducation and treatment-as-usual
control groups (e.g., Daley et al., 1998; Martino et al., 1999; Steinberg et al., 2004). A recent
quasi-experimental pilot study examined the effect of two group MI (tobacco-related vs. general
substance use-related) interventions on smoking cessation treatment-seeking behavior in a
sample of homeless veterans seeking treatment for alcohol use in an outpatient clinic (Santa Ana,
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LaRowe, Armeson, Lamb, & Hartwell, 2016). That study found that a multi-session, tobaccomodified version of group MI enhanced motivation to quit smoking and led to significantly
higher treatment-seeking behavior compared to a group MI condition that focused on general
abstinence from substances. In addition, participants in the latter study engaged in the same
pattern of treatment-seeking behavior as participants in our present study, such that a larger
number of veterans requested NRT compared to other smoking cessation aids (smoking cessation
classes or combination of classes and NRT). One advantage of our study over the previous
quasi-experimental design is that stronger evidence of causality is provided by the randomized
design. It also demonstrated similar results in the context of a brief, individual MI intervention.
Thus, the efficacy of tobacco-related MI may translate across treatment modalities and across
treatment lengths. Our small, randomized-controlled study provides further evidence of the
utility of MI in engaging veteran smokers undergoing treatment for substance use in treatment
for smoking cessation.
Although our study is consistent with previous studies testing the effect of MI on
smoking-cessation treatment behavior among different populations, these studies did not
examine the mechanisms of change driving the effect of the intervention on the outcome. In the
present study, we were interested in exploring the processes by which our brief MI intervention
could lead to smoking cessation treatment-seeking behavior. We hypothesized that changes in
motivation and self-efficacy would underlie the effect of MI on the study outcome. This study
did not provide a clear understanding as to how the brief MI intervention worked, as motivation
to quit smoking and self-efficacy significantly improved for the entire sample, regardless of
condition. Mediation analyses showed that motivation and self-efficacy did not mediate the
effect of the intervention on the study outcome.
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One possible explanation for the lack of mediational evidence is that our study was small
and, as such, was powered to test only the main effect of the intervention (MI vs. Health
Education) on smoking cessation treatment-seeking behavior. Although we were interested in
exploring the mechanisms of change regarding MI, our study was not powered for mediation
analyses. Another possible explanation for the lack of mediational evidence is that the measures
may not have been sensitive enough to detect particular aspects of motivation and self-efficacy
that may lead individuals to change their behavior. Previous research suggests that motivation,
for instance, could be a multidimensional and dynamic process (Simmons, Heckman, Ditre, &
Brandon., 2010), which the Contemplation Ladder may not capture. Last but not least, it is worth
noting that our lack of mediational evidence in this area could also be explained by the makeup
of our sample and the treatment setting. Our participants were veterans who actively sought out
substance use treatment for one reason or another (self-imposed motivation to change behavior
or court mandated treatment for substance use). It may be that their motivation and self-efficacy
to change problematic behaviors were already influenced by their enrollment in the substance
use program.
We also found that number of medical conditions and prescribed medications for these
conditions predicted smoking cessation treatment-seeking behavior. It is possible that patients
who have more diagnoses and are using more medications are the ones who are most
comfortable seeking help in general, which could explain why they also seek smoking cessation
help. Another explanation is that individuals with more medical conditions may be more likely to
have access to and contact with health providers at the VA, which could increase opportunities
for individuals to ask for smoking cessation aid.
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Limitations
Although the findings of the present study are encouraging, it has a number of limitations
that are worth considering. First, we only collected outcome data on the participants exiting a
four-week outpatient treatment program for substance use and did not collect follow-up data on
the participants’ smoking status. The ultimate goal is to promote actual smoking cessation, so
future studies should extend outcomes to include this behavior change in addition to initial
treatment-seeking. Albeit, MI alone may be insufficient for producing smoking cessation in
many individuals, which is why treatment-seeking and engagement are worthy proximal
outcomes. Second, we did not record smoking cessation treatment compliance. Future studies
may find this information valuable, as just requesting services does not necessarily mean that
these services are going to be utilized effectively. Third, our randomization was not entirely
effective as there were significant differences between groups on key baseline variables,
particularly motivation to quit smoking. Fourth, the study was conducted at an outpatient
substance use clinic at a VA hospital. The results from this study may not represent the general
population or groups of smokers with different needs. Fifth, the weekly tobacco recovery
education class posed a limitation for this study as it provided information to participants that
could have motivated them to seek help quitting smoking. However, this class has not resulted in
more than 10% spontaneous smoking cessation treatment-seeking behavior and it was provided
to all participants in this study regardless of condition. Although not a limitation, we included an
active control group, which might have reduced the likelihood of finding differences between
groups, and it prevented us from quantifying the effect of MI compared to no treatment. Finally,
as noted earlier, our study was powered only to examine the effectiveness of an MI intervention
on engaging veteran smokers undergoing treatment for substance dependence in smoking
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cessation treatment. As an exploratory aim, we wanted to examine the intervention’s
mechanisms of change. However, our study was not powered for mediation analyses. Future
studies may consider replicating this study with a larger sample size, powered for more
sophisticated process analyses.
Conclusion and Implications
In conclusion, this study found that veteran smokers undergoing treatment for substance
dependence may be receptive to messages about smoking cessation. However, the way in which
these messages are delivered appears to make a difference. In the case of our study, an MI
approach led to more veteran smokers seeking help to quit smoking (40%) than a health
education modality. It is important to note, however, that 23% of participants in the health
education condition sought treatment to quit smoking, which is higher than would be expected
for non-active control groups. Previous studies that included usual care control groups found a
rate of treatment-seeking behavior approximately 10% (Daley et al., 1998; Martino et al., 1999;
Steinberg et al., 2004). This suggests that educating veteran smokers about the health effects of
cigarette smoking is somewhat helpful; however, using an MI approach with this population
appears to be more effective in leading veteran smokers to take action to quit smoking. The
findings from the health education control condition could be more promising than problematic,
as it may elucidate the fact that simply discussing smoking cessation with individuals and the
consequences on their health may make them more likely to seek smoking cessation treatments.
The latter may support the idea that something is better than nothing and in settings that lack MI
training, health education may lead some smokers to seek services to quit smoking.
Although it was not measured in our study, smokers (veterans or not) who are undergoing
treatment for smoking cessation do not appear to be at risk for relapse to other abused substances
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(e.g., Cooney et al., 2009). In fact, ample evidence suggests that concurrent smoking cessation
and substance dependence treatment are more likely to maintain patients’ recovery from
substances. This evidence points to the importance of engaging individuals in treatment for
smoking cessation, as this is the first step towards quitting smoking. Furthermore, in medical
settings, brief motivational interventions may be all that is feasible to deliver to patients.
Although small, this study showed that a brief motivational intervention promoted access to
smoking cessation resources, and such an intervention could be implemented in many types of
treatment environments, including primary care and other specialty clinics. Given the relative
success seen in our study, it would be interesting to see how effective brief MI interventions are
in other medical settings and how they might dovetail with utilization of the 5A’s by healthcare
providers. Of course, this motivational intervention will need to be paired with evidence-based
cessation interventions to capitalize upon the motivational enhancement. Possibilities for such
interventions include pharmacotherapy, brief physician advice (e.g., the “5 A’s”), telephone
quitlines, self-help (e.g., Brandon, Simmons, Sutton, Unrod, Harrell et al., 2016), through
intensive face-to-face counseling (see Fiore et al., 2008, for review of interventions and
efficacies). In sum, this study provides encouragement that even for a population as challenging
as veterans receiving substance abuse treatment, a brief motivational intervention can initiate the
process of smoking cessation, with its numerous documented downstream health benefits.
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